Patent Assignment
Reel/Frame 073022/0053
Assignment of Assignor's Interest
Recorded: 2025-11-24
Pages: 4
Assignors
PRESTRELSKI, STEVEN
Executed: 2018-05-16
NEWSWANGER, BRETT
Executed: 2018-05-31
CUMMINS, MARTIN
Executed: 2018-05-31
RIDDELL, MICHAEL
Executed: 2018-08-28
Assignee
XERIS PHARMACEUTICALS, INC.
1375 WEST FULTON STREET, SUITE 1300, CHICAGO, ILLINOIS, 60607
Covered Properties
(2)
Treatment of Exercise-Induced Hypoglycemia in Type 1 and Insulin Using Type 2 Diabetes
Application:
16/955,698 →
Publication:
US 2021/0008170
Treatment of Exercise-Induced Hypoglycemia in Type 1 and Insulin Using Type 2 Diabetes
Related Assignments
(4)
Other recorded transfers of the patents in this record — the chain of ownership.
Intellectual Property Security Agreement
May 4, 2021
From: XERIS PHARMACEUTICALS, INC.
To: OXFORD FINANCE LLC, AS COLLATERAL AGENT
Reel/Frame 056135/0800 →
Security Interest
Mar 9, 2022
From: XERIS PHARMACEUTICALS, INC.; STRONGBRIDGE DUBLIN LIMITED
To: HAYFIN SERVICES LLP
Reel/Frame 059552/0066 →
Reassignment and Release of Security Interest
Mar 10, 2022
From: OXFORD FINANCE LLC
To: XERIS PHARMACEUTICALS, INC.
Reel/Frame 059358/0714 →
Security Interest
Mar 5, 2024
From: XERIS PHARMACEUTICALS, INC.; STRONGBRIDGE DUBLIN LTD.
To: HAYFIN SERVICES LLP
Reel/Frame 066647/0595 →